Brenntag SE

XTRA:BNR Stock Report

Market Cap: €8.7b

Brenntag Future Growth

Future criteria checks 1/6

Brenntag is forecast to grow earnings and revenue by 13.4% and 1.8% per annum respectively. EPS is expected to grow by 13.5% per annum. Return on equity is forecast to be 12.3% in 3 years.

Key information

13.4%

Earnings growth rate

13.46%

EPS growth rate

Trade Distributors earnings growth12.8%
Revenue growth rate1.8%
Future return on equity12.32%
Analyst coverage

Good

Last updated27 Aug 2026

Recent future growth updates

Analysis Article • Aug 15

Brenntag SE Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Brenntag SE ( ETR:BNR ) shareholders are probably feeling a little disappointed, since its shares fell 4.2% to €61.38...

Recent updates

Narrative Update • Sep 17

BNR: Modest Multiple Repricing Will Limit Future Upside Despite Rating Shift

The Brenntag fair value estimate has moved from €44.00 to €47.00 as analysts factor in updated discount rate assumptions, modestly adjusted revenue growth and margin expectations, and a slightly higher future P/E multiple, in line with recent price target moves to €55 to €56 and rating changes on the stock. Analyst Commentary Recent research updates on Brenntag point to a more balanced but still cautious stance.
Narrative Update • Sep 03

BNR: Pricing Tailwinds And Mixed Ratings Will Shape A Fairly Balanced Outlook

The Brenntag analyst price target has edged higher to about €57.70 from roughly €56.40. This reflects analysts' updated assumptions on fair value, revenue growth, margins and a higher future P/E, following recent revisions to Street ratings and targets in the €55 to €57 range.
Analysis Article • Aug 15

Brenntag SE Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Brenntag SE ( ETR:BNR ) shareholders are probably feeling a little disappointed, since its shares fell 4.2% to €61.38...
Narrative Update • Aug 10

BNR: Pricing Normalization And Resilient Demand Are Expected To Support Re Rating

The analyst price target for Brenntag has moved from about €68 to roughly €70, as analysts weigh mixed rating changes and updated views on pricing risks, demand resilience and relative valuation, which are reflected in the revised fair value, discount rate, revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent broker updates on Brenntag point to a more balanced view, with several bullish analysts shifting from negative stances to neutral ones and lifting price targets into the €52 to €57 range.
Narrative Update • Jun 22

BNR: Easing Pricing Tailwinds Will Pressure Margins And Limit Upside Potential

The analyst price target for Brenntag has been reduced by €10 to €57. Analysts are factoring in Brenntag's exposure to easing pricing tailwinds in certain regions, while also noting relatively resilient demand and a steadier pricing backdrop compared with some peers.
Narrative Update • Jun 06

BNR: Resilient Demand Expectations Will Still Leave Execution Risks In Focus

The analyst fair value estimate for Brenntag has increased from €42.00 to €44.00, reflecting higher price targets from analysts, including recent upgrades that cite more resilient second half demand and a smaller expected price roll off compared with peers. Analyst Commentary Recent research on Brenntag shows a mix of optimism and caution.
Narrative Update • May 23

BNR: Resilient Demand And Higher Discount Rate Will Shape Fairly Balanced Outlook

The analyst price target for Brenntag has shifted from roughly €53.86 to about €56.43. Analysts cite more resilient second half demand, a smaller price roll off versus peers, and recent rating and target increases from several firms as key drivers of the change.
Narrative Update • May 01

BNR: Higher Discount Rate And Lower P E May Cap Share Price

Analysts have trimmed their Brenntag price target slightly from about €54.50 to roughly €53.86. This reflects updates to assumptions on discount rate, revenue growth, profit margin and future P/E following recent UBS and Deutsche Bank research.
Narrative Update • Apr 15

BNR: Dividend And Epoxy Expansion Are Expected To Support Re Rating

Analysts have nudged their price target for Brenntag slightly higher to about €68, citing updated assumptions for revenue growth, profit margins and a lower future P/E multiple following recent research, including an upgrade at a major bank. Analyst Commentary Recent research points to a more constructive tone around Brenntag, with bullish analysts aligning their models to the updated assumptions on revenue growth, profit margins and future P/E multiples that underpin the new price target around €68.
Narrative Update • Apr 01

BNR: Sector Headwinds And Execution Risks Will Sustain Earnings Pressure

Narrative Update The analyst price target for Brenntag has been adjusted to €50. Analysts cite updated 2026 sector views, a more cautious stance on chemical distribution and staffing peers, and revised assumptions for discount rate, revenue growth, profit margin, and future P/E.
Narrative Update • Mar 18

BNR: Distribution Execution And Staffing Risks Will Sustain Earnings Pressure

Analysts have reduced their Brenntag price target to €50 from €63, citing a more cautious stance on chemical distribution and staffing within the broader European business services group. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Brenntag, pointing to risks around execution in chemical distribution and staffing within the broader European business services group.
Narrative Update • Mar 04

BNR: Expanded Epoxy Partnership Will Support A More Constructive Long Term View

Our Brenntag narrative has been updated to reflect a lower analyst price target of €50, down from €63, as analysts factor in more cautious assumptions on revenue growth, profit margins and sector conditions, even while using a slightly higher discount rate and a higher future P/E multiple. Analyst Commentary The latest rating and price target move to €50 comes as part of a broader 2026 reassessment of European business services and chemical distribution names.
Narrative Update • Feb 18

BNR: Chemical Distribution Concerns Will Sustain Earnings Pressure And Extended Multiple Compression

Analysts have cut their price target on Brenntag to €50 from €63, reflecting a more cautious view on chemical distribution as they update their 2026 outlook and favor other business services names instead. Analyst Commentary Bearish analysts have moved Brenntag to a less favorable rating and cut the price target to €50 from €63, signaling a stricter view on what they are willing to pay for the shares in the medium term.
Narrative Update • Feb 03

BNR: Chemical Distribution Execution Risk Will Pressure Earnings And Sustain Multiple Compression

Narrative update on Brenntag Analysts have trimmed their average price target for Brenntag to €50 from €63. This reflects a more cautious view on chemical distribution and related business services, while still keeping fair value assumptions broadly unchanged.
Narrative Update • Jan 20

BNR: Staffing And Chemical Distribution Risks Will Pressure Earnings And Sustain Multiple Compression

Narrative Update on Brenntag Brenntag's analyst price target has been cut to €50 from €63, with analysts citing a more cautious view on chemical distribution and staffing exposure within their 2026 outlook. Analyst Commentary Bearish analysts have shifted their stance on Brenntag, cutting the price target to €50 from €63 and moving the rating to Underweight.
Narrative Update • Jan 06

BNR: Weaker Chemical Demand Will Pressure Earnings And Sustain Multiple Compression

Analysts have trimmed their average price targets on Brenntag to a range around €45 to €50, reflecting more cautious views on chemical distribution volumes and the company's growth profile. Analyst Commentary Recent research updates on Brenntag point to a more cautious stance on the stock, with several bearish analysts rethinking both ratings and price targets in light of concerns around chemical distribution and the company's growth profile.
Analysis Article • Dec 31

Is There An Opportunity With Brenntag SE's (ETR:BNR) 49% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Brenntag fair value estimate is €96.93 Current share price of...
Narrative Update • Dec 18

BNR: Weaker Chemical Demand Will Pressure Earnings And Drive Multiple Compression

Analysts have reduced their price target on Brenntag from about EUR 47 to EUR 42. This reflects expectations for a weaker growth profile and a deteriorating chemical market backdrop, even as margins hold up and valuation multiples compress slightly.
Narrative Update • Dec 04

BNR: Share Price Will Rebound As Cost Efficiencies Support Earnings Resilience

The analyst price target for Brenntag has been trimmed slightly from EUR 54.67 to about EUR 54.50, as analysts factor in a weaker chemical market backdrop, lower expected growth, and modestly softer profitability assumptions. Analyst Commentary Recent Street research reflects a more cautious stance on Brenntag, with several firms lowering price targets and reassessing the companys risk reward profile in light of a softer chemical demand outlook.
Analysis Article • Nov 29

Here's Why Brenntag (ETR:BNR) Can Manage Its Debt Responsibly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Narrative Update • Nov 20

BNR: Share Price Will Rebound As Chemical Market Challenges Ease

Brenntag's analyst fair value estimate has declined from €57.24 to €54.67, as analysts cite a weaker growth outlook and challenging chemical market conditions as reasons for the reduced price target. Analyst Commentary Recent analyst updates on Brenntag reflect a shift in sentiment as experts weigh the company’s outlook in the context of ongoing market challenges and valuation considerations.
Analysis Article • Nov 09

Brenntag SE's (ETR:BNR) Shares May Have Run Too Fast Too Soon

It's not a stretch to say that Brenntag SE's ( ETR:BNR ) price-to-earnings (or "P/E") ratio of 15.8x right now seems...
Narrative Update • Nov 05

BNR: Share Price Will Reflect Sector Headwinds as Market Conditions Stabilize

Brenntag's consensus analyst price target has been lowered noticeably in recent updates. Analysts cite a challenging chemical market environment and expectations for slower growth as key factors behind the revised outlook.
Narrative Update • Oct 22

Analyst Commentary Signals Lower Growth Expectations as Brenntag Faces Reduced Price Targets

Brenntag's analyst price target has been revised downward by approximately EUR 3 to EUR 57, as analysts point to ongoing reductions in expected growth and profitability in light of a challenging market backdrop. Analyst Commentary Recent analyst coverage of Brenntag reflects a cautious sentiment across the market, with lowered price targets and revised outlooks highlighting ongoing concerns about the company's growth prospects and market challenges.
Narrative Update • Oct 08

Specialty Chemicals And Biopharma Expansion Will Unlock Long-Term Value

Brenntag's analyst price target has been reduced by several euros, as analysts cite lower expectations for revenue growth, profit margins, and sector cyclicality. Analyst Commentary Recent street research updates reflect a mixed outlook on Brenntag, with several analysts adjusting their ratings and lowering price targets in light of the company’s ongoing performance and sector trends.
Analysis Article • Sep 20

Return Trends At Brenntag (ETR:BNR) Aren't Appealing

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
Narrative Update • Sep 05

Specialty Chemicals And Biopharma Expansion Will Unlock Long-Term Value

Analysts have maintained a cautious outlook on Brenntag due to its increased earnings cyclicality, macroeconomic uncertainties, and negative FX impacts, resulting in an unchanged consensus price target at €62.83. Analyst Commentary Bearish analysts cite increased cyclicality in Brenntag’s business versus specialty distributors, leading to greater earnings volatility.
User avatar
New Narrative • Nov 25

Decisive Acquisitions And Digital Innovations Propel Transformation Amid Challenges

Strategic focus on divisional optimization and cost containment is set to enhance revenue and improve net margins by reducing expenses.

Earnings and Revenue Growth Forecasts

XTRA:BNR - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202816,04362164397712
12/31/202715,54156565296714
12/31/202615,59456056178812
6/30/202615,156365513803N/A
3/31/202614,762228657948N/A
12/31/202515,172265674967N/A
9/30/202515,649418672990N/A
6/30/202516,000423587908N/A
3/31/202516,307530569901N/A
12/31/202416,237536564907N/A
9/30/202416,1915456721,054N/A
6/30/202416,2106038211,188N/A
3/31/202416,2916401,0781,421N/A
12/31/202316,8157151,3431,664N/A
9/30/202317,6076821,2861,565N/A
6/30/202318,6197531,2791,551N/A
3/31/202319,4238531,0551,322N/A
12/31/202219,429887690957N/A
9/30/202218,737843421659N/A
6/30/202217,374754221442N/A
3/31/202215,783600135346N/A
12/31/202114,383448189389N/A
9/30/202113,221501435613N/A
6/30/202112,364461684864N/A
3/31/202111,7164509041,092N/A
12/31/202011,7954671,0201,219N/A
9/30/202012,0454659651,174N/A
6/30/202012,4194757861,009N/A
3/31/202012,851476N/A922N/A
12/31/201912,822467N/A879N/A
9/30/201912,829483N/A787N/A
6/30/201912,796467N/A621N/A
3/31/201912,757460N/A549N/A
12/31/201812,550461N/A375N/A
9/30/201812,288394N/A340N/A
6/30/201811,959383N/A341N/A
3/31/201811,745372N/A317N/A
12/31/201711,743361N/A405N/A
9/30/201711,502401N/A394N/A
6/30/201711,229394N/A450N/A
3/31/201710,892389N/A517N/A
12/31/201610,498360N/A540N/A
9/30/201610,337334N/A654N/A
6/30/201610,325335N/A641N/A
3/31/201610,352340N/A633N/A
12/31/201510,346365N/A594N/A
9/30/201510,384393N/A501N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BNR's forecast earnings growth (13.4% per year) is above the savings rate (2.1%).

Earnings vs Market: BNR's earnings (13.4% per year) are forecast to grow slower than the German market (15.1% per year).

High Growth Earnings: BNR's earnings are forecast to grow, but not significantly.

Revenue vs Market: BNR's revenue (1.8% per year) is forecast to grow slower than the German market (6.7% per year).

High Growth Revenue: BNR's revenue (1.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BNR's Return on Equity is forecast to be low in 3 years time (12.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 01:09
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Brenntag SE is covered by 30 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Gaurav JainBarclays
James StewartBarclays